Accueil   Diary - News   All news ERYTECH presents new preclinical data on ERY-MET

ERYTECH presents new preclinical data on ERY-MET

ERYTECH PRESENTS NEW PRECLINICAL DATA ON ERY-MET AT THE 2017 ASCO GI SYMPOSIUM

 

ERYTECH Pharma, the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs (the "Company"), today announced new data supporting the second Company’s product candidate ERY-MET will be presented at the 2017 Gastrointestinal Cancers Symposium co-sponsored by the American Society of Clinical Oncology (ASCO GI), being held January 19 – 21, 2017 in San Francisco, California.

 

 

Read the press release